Phreesia Inc (PHR)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $795.75M
Last updated: Nov 17, 2026 at 4:15 PM ET
Phreesia Inc (PHR) Statistics
Phreesia (PHR) has a market cap of $795.75M. Its share count is up 3.84% from a year earlier.
Total Valuation
| Market Cap | $795.75M |
|---|---|
| Latest price (Nov 17, 2026) | $12.55 |
Key Dates
The next earnings report is set for Dec 2, 2026, after the close.
| Next Earnings Date | Dec 2, 2026, after the close |
|---|---|
| Last Earnings Date | Sep 2, 2026 |
| Fiscal Year End | January |
Valuation Ratios
Sales and book value multiples are 1.5x and 2.1x.
| P/E Ratio | 12.9x |
|---|---|
| Forward P/E | 40.1x |
| P/S Ratio | 1.5x |
| Forward P/S | 1.5x |
| P/B Ratio | 2.1x |
| P/TBV Ratio | 6.2x |
| P/FCF Ratio | 11.5x |
| P/OCF Ratio | 8.7x |
| PEG Ratio | 0.2 |
Price Statistics
The stock is down 42.35% over 52 weeks and trades 10.96% above its 50-day average.
| Beta (1Y) | 0.17 |
|---|---|
| 52-Week Change | -42.35% |
| 1-Month Change | +11.26% |
| 3-Month Change | +4.93% |
| 6-Month Change | +36.86% |
| 5-Year Change | -82.36% |
| Total Return (1Y) | -42.35% |
| Total Return (3Y CAGR) | -7.21% |
| Total Return (5Y CAGR) | -28.77% |
| Return vs SPY (1Y) | -47.53% |
| Max Drawdown (1Y) | -60.91% |
| Max Drawdown (3Y) | -75.24% |
| Sharpe Ratio (1Y) | -0.72 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $11.31 |
| 200-Day Average | $10.78 |
| 52-Week Range | $7.77 to $21.24 |
| RSI (14 Days) | 55.1 |
| Average Volume (20 Days) | 628.47K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.76x current liabilities, and total debt is 0.18x shareholder equity.
| Current Ratio | 1.76x |
|---|---|
| Quick Ratio | 1.76x |
| Debt / Equity | 0.18x |
| Debt / EBITDA | 1.26x |
| Debt / FCF | 0.98x |
Returns and Efficiency
Return on invested capital is 2.72% over the last 12 months, against a 5-year average of -31.87%.
| Return on Equity (ROE) | 2.81% |
|---|---|
| Return on Assets (ROA) | 1.61% |
| Return on Invested Capital (ROIC) | 2.72% |
| Return on Capital Employed (ROCE) | 2.37% |
| ROE (5Y Average) | -33.07% |
| ROA (5Y Average) | -24.64% |
| ROIC (5Y Average) | -31.87% |
| Asset Turnover | 0.96x |
| Receivables Turnover | 5.67x |
Scores
PHR has an Altman Z-Score of 1.02, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.02 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $507.79M over the last 12 months is up 12.93% from the 12 months before.
| Revenue | $507.79M |
|---|---|
| Revenue Growth (YoY) | +12.93% |
| Gross Profit | $475.20M |
| Operating Income | $12.54M |
| Pretax Income | $2.76M |
| Net Income | $10.45M |
| EBITDA | $52.90M |
| EBIT | $11.92M |
| Reported EPS (TTM) | $0.97 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 57.47% of the $646.98M in total assets.
| Total Debt | $66.45M |
|---|---|
| Working Capital | $109.67M |
| Shareholder Equity | $371.85M |
| Book Value Per Share | $6.01 |
| Tangible Book Value | $125.86M |
| Tangible Book Per Share | $2.03 |
| Total Assets | $646.98M |
| Total Liabilities | $275.13M |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $23.86M of capital spending, operating cash flow left $67.52M of free cash flow.
| Operating Cash Flow | $91.38M |
|---|---|
| Capital Expenditures | $23.86M |
| Free Cash Flow | $67.52M |
| FCF Per Share | $1.09 |
| Depreciation and Amortization | $40.98M |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is 2.47%, against a 5-year average of -34.23%.
| Gross Margin | 93.58% |
|---|---|
| Operating Margin | 2.47% |
| Pretax Margin | 0.54% |
| Net Margin | 2.06% |
| EBITDA Margin | 10.42% |
| EBIT Margin | 2.35% |
| FCF Margin | 13.30% |
| Gross Margin (5Y Average) | 75.04% |
| Operating Margin (5Y Average) | -34.23% |
| Net Margin (5Y Average) | -34.00% |
Growth
Revenue grew 19.60% a year over 3 years.
| Revenue Growth (3Y CAGR) | +19.60% |
|---|---|
| Revenue Growth (5Y CAGR) | +26.45% |
| Book Value Per Share Growth (2Y CAGR) | +9.07% |
| Tangible Book Per Share Growth (2Y CAGR) | -45.21% |
Dividends and Yields
PHR does not pay a dividend. Its free cash flow yield is 8.69%.
| Earnings Yield | 7.75% |
|---|---|
| FCF Yield | 8.69% |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
Peer Position
Against 6 similar companies, PHR has the lowest P/E.
P/E RatioPeer median 35.5x
P/S RatioPeer median 2.6x
ROICPeer median -6.95%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.95%
| P/E Ratio | 12.9x vs 35.5x median |
|---|---|
| P/S Ratio | 1.5x vs 2.6x median |
| ROIC | 2.72% vs -6.95% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +12.93% vs +11.95% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.47% and EPS growth at 12.64% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.47% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.64% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PHR
What is PHR's market cap?
Phreesia has a market cap of $795.75M.
What is PHR's P/E ratio?
Phreesia has a trailing P/E ratio of 12.9x and a forward P/E of 40.1x.
How many shares of PHR are outstanding?
Phreesia has 61.88M shares outstanding. The count is up 3.84% from a year earlier.
Does PHR pay a dividend?
No. Phreesia does not pay a dividend.
PHR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors